These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30312728)

  • 21. Human Epidermal Growth Factor Receptor-3 Expression Is Regulated at Transcriptional Level in Breast Cancer Settings by Junctional Adhesion Molecule-A via a Pathway Involving Beta-Catenin and FOXA1.
    Cruz RGB; Madden SF; Richards CE; Vellanki SH; Jahns H; Hudson L; Fay J; O'Farrell N; Sheehan K; Jirström K; Brennan K; Hopkins AM
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells.
    Chu B; Liu F; Li L; Ding C; Chen K; Sun Q; Shen Z; Tan Y; Tan C; Jiang Y
    Cell Death Dis; 2015 Mar; 6(3):e1686. PubMed ID: 25766325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression.
    Murakami M; Giampietro C; Giannotta M; Corada M; Torselli I; Orsenigo F; Cocito A; d'Ario G; Mazzarol G; Confalonieri S; Di Fiore PP; Dejana E
    PLoS One; 2011; 6(6):e21242. PubMed ID: 21695058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling.
    Alvarado AG; Turaga SM; Sathyan P; Mulkearns-Hubert EE; Otvos B; Silver DJ; Hale JS; Flavahan WA; Zinn PO; Sinyuk M; Li M; Guda MR; Velpula KK; Tsung AJ; Nakano I; Vogelbaum MA; Majumder S; Rich JN; Lathia JD
    Neuro Oncol; 2016 May; 18(5):656-66. PubMed ID: 26374689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Junctional adhesion molecule-A, an epithelial-mesenchymal transition inducer, correlates with metastasis and poor prognosis in human nasopharyngeal cancer.
    Tian Y; Tian Y; Zhang W; Wei F; Yang J; Luo X; Zhou T; Hou B; Qian S; Deng X; Qiu Y; Yao K
    Carcinogenesis; 2015 Jan; 36(1):41-8. PubMed ID: 25416560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates herceptin activity in vivo.
    Jerome L; Alami N; Belanger S; Page V; Yu Q; Paterson J; Shiry L; Pegram M; Leyland-Jones B
    Cancer Res; 2006 Jul; 66(14):7245-52. PubMed ID: 16849573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 ('Iressa') is independent of EGFR expression level.
    Campiglio M; Locatelli A; Olgiati C; Normanno N; Somenzi G; Viganò L; Fumagalli M; Ménard S; Gianni L
    J Cell Physiol; 2004 Feb; 198(2):259-68. PubMed ID: 14603528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
    Huang KF; Zhang GD; Huang YQ; Diao Y
    Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification.
    Tanizaki J; Okamoto I; Fumita S; Okamoto W; Nishio K; Nakagawa K
    Oncogene; 2011 Sep; 30(39):4097-106. PubMed ID: 21499301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38/ERK signaling pathway by binding to JAM-2.
    Li GC; Cao XY; Li YN; Qiu YY; Li YN; Liu XJ; Sun XX
    J Cell Physiol; 2018 Sep; 233(9):7379-7390. PubMed ID: 29575013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell-Cell Interactions in Tumor Progression.
    Lauko A; Mu Z; Gutmann DH; Naik UP; Lathia JD
    Cancer Res; 2020 Nov; 80(22):4878-4885. PubMed ID: 32816855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression.
    Smith YE; Wang G; Flynn CL; Madden SF; MacEneaney O; Cruz RGB; Richards CE; Jahns H; Brennan M; Cremona M; Hennessy BT; Sheehan K; Casucci A; Sani FA; Hudson L; Fay J; Vellanki SH; O'Flaherty S; Devocelle M; Hill ADK; Brennan K; Sukumar S; Hopkins AM
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment.
    Bednarek R; Selmi A; Wojkowska D; Karolczak K; Popielarski M; Stasiak M; Salifu MO; Babinska A; Swiatkowska M
    Breast Cancer Res Treat; 2020 Jan; 179(2):325-335. PubMed ID: 31650345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib.
    Valabrega G; Capellero S; Cavalloni G; Zaccarello G; Petrelli A; Migliardi G; Milani A; Peraldo-Neia C; Gammaitoni L; Sapino A; Pecchioni C; Moggio A; Giordano S; Aglietta M; Montemurro F
    Breast Cancer Res Treat; 2011 Nov; 130(1):29-40. PubMed ID: 21153051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
    McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
    Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual inhibition of Type I and Type III PI3 kinases increases tumor cell apoptosis in HER2+ breast cancers.
    Young CD; Arteaga CL; Cook RS
    Breast Cancer Res; 2015 Dec; 17():148. PubMed ID: 26637440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysosomal protein turnover contributes to the acquisition of TGFβ-1 induced invasive properties of mammary cancer cells.
    Kern U; Wischnewski V; Biniossek ML; Schilling O; Reinheckel T
    Mol Cancer; 2015 Feb; 14():39. PubMed ID: 25744631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor.
    Lathia JD; Li M; Sinyuk M; Alvarado AG; Flavahan WA; Stoltz K; Rosager AM; Hale J; Hitomi M; Gallagher J; Wu Q; Martin J; Vidal JG; Nakano I; Dahlrot RH; Hansen S; McLendon RE; Sloan AE; Bao S; Hjelmeland AB; Carson CT; Naik UP; Kristensen B; Rich JN
    Cell Rep; 2014 Jan; 6(1):117-29. PubMed ID: 24373972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor and anticancer stem cell activity of a poly ADP-ribose polymerase inhibitor olaparib in breast cancer cells.
    Shimo T; Kurebayashi J; Kanomata N; Yamashita T; Kozuka Y; Moriya T; Sonoo H
    Breast Cancer; 2014 Jan; 21(1):75-85. PubMed ID: 22454224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
    Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.